Producing low-immunogenicity, high-stability mRNA with dsRNA reduction to <0.005% (LLOQ)

Optimizing mRNA design for therapeutic applications is critical to ensure maximum protein expression, low impurities and a reduced immune response. This poster describes how to efficiently generate lower immunogenicity mRNA for downstream applications while also reducing dsRNA using the INCOGNITO™ mScript™ Complete mRNA Production Systems. NEW INTERACTIVE FORMAT Listen to our expert speaker. Watch the video. Read the summary. Focus in on the data. Download the PDF. It has never been easier to quickly access the information you want. All in one place—at the click of a button.

Please enter your email to access content Read now